Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.6900 (6.12%) ($16.5500 - $17.8300) on Wed. Apr. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.98% (three month average) | RSI | 67 | Latest Price | $17.6900(6.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.7% a day on average for past five trading days. | Weekly Trend | HALO advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(52%) IWO(51%) IWM(47%) ARKG(45%) IWC(45%) | Factors Impacting HALO price | HALO will decline at least -1.99% in a week (0% probabilities). VIXM(-32%) VXX(-15%) UUP(-13%) TLT(-4%) USO(4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.99% (StdDev 3.98%) | Hourly BBV | 0 () | Intraday Trend | 5.3% | | | |
|
5 Day Moving Average | $16.95(4.37%) | 10 Day Moving Average | $17.25(2.55%) | 20 Day Moving Average | $16.61(6.5%) | To recent high | -19% | To recent low | 27.3% | Market Cap | $2.418b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |